Objective: To determine whether there is a higher prevalence of menstr
ual symptoms in women seropositive for the human immunodeficiency viru
s (HIV) compared to a matched control group and to examine the relatio
n between menstrual symptomatology and immunosuppression. Methods: In
a cross-sectional study, 55 HIV-seropositive women and a matched contr
ol group underwent detailed gynecologic assessment. The prevalence of
regular cycles, oligomenorrhea, amenorrhea, menorrhagia, dysmenorrhea,
and dyspareunia was assessed in the two groups. Any association with
clinical disease or CD4 lymphocyte count was sought. Results: There we
re no significant differences in the prevalence of oligomenorrhea, ame
norrhea, menorrhagia, dysmenorrhea, or dyspareunia between the groups.
Furthermore, no differences were demonstrated between symptomatic and
asymptomatic women infected by HIV, nor was any correlation found bet
ween CD4 lymphocyte count and menstrual loss or dysmenorrhea. Conclusi
on: Infection with HIV and related immunosuppression do not seem to ha
ve a clinically significant effect on menstruation.